or nebulization (7%), or ipratropium bromide in a fixed-dose combination with albuterol (38%). Overall, exposure to anticholinergics was associated with a 29% higher risk of CVEs relative to no ...

Overall, cilomilast is well tolerated, with 4 clinical trials encompassing 1151 patients reporting the most common adverse effects to be diarrhea, nausea, dizziness, and headaches. [10,11,12,13 ...

Ipratropium (brand name, Atrovent HFA; Boehringer-Ingelheim) is a short-acting bronchodilator. It is used to prevent wheezing, shortness of breath, coughing, and chest tightness in people with COPD.

The BOREAS Phase III trial showed DUPIXENT reduced exacerbations by 30% and improved lung function by 160 mL at 52 weeks.

Albuterol (also known as salbutamol) is a short-acting bronchodilator. It is used in emergency situations or for quick relief use as needed. Bronchodilators work by relaxing and opening the airways to ...

Bronchodilators to open the airways (e.g., albuterol or ipratropium bromide and albuterol) Untreated anaphylaxis can lead to hypotension (low blood pressure), incontinence, fainting, shock ...

However, also like Primatene, Asthmanefrin was significantly less effective at controlling asthma symptoms than prescription albuterol. Primatene Mist inhalers provide temporary relief from mild, ...

RESULTS Deaths from asthma were associated with a history of clinically severe asthma (OR 6.29 (95% CI 1.84 to 21.52)), chest pain (OR 3.78 (95% CI 1.06 to 13.5)), biochemical or haematological ...

A tapering course of prednisone and inhaled albuterol were prescribed ... furosemide and piperacillin–tazobactam and inhaled ipratropium were administered. Diagnostic tests were performed ...

Bronchodilators to further open the airways (e.g., albuterol or an ipratropium bromide and albuterol combination) Allergic reactions and anaphylaxis are caused by exposure to an allergen.